Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 08, 2021 16:15 ET | Source: iBio, Inc.

iBio Establishes Oncology Drug Discovery Pipeline with Three New Antibody Programs

BRYAN, Texas, July 08, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, has taken another major step...
June 09, 2021 16:30 ET | Source: iBio, Inc.

iBio Further Strengthens Board with Appointment of Veteran Biopharmaceutical Executive, Eef Schimmelpennink

BRYAN, Texas, June 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today the...
May 19, 2021 16:30 ET | Source: iBio, Inc.

iBio to Present at the UBS Global Healthcare Virtual Conference

BRYAN, Texas, May 19, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that...
May 17, 2021 07:00 ET | Source: iBio, Inc.

iBio Reports Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update

BRYAN, Texas., May 17, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its...
May 10, 2021 08:15 ET | Source: iBio, Inc.

iBio to Report Fiscal 2021 Third Quarter Financial Results and Provide Corporate Update on Monday, May 17, 2021

BRYAN, Texas, May 10, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that it will...
May 06, 2021 16:15 ET | Source: iBio, Inc.

iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program

BRYAN, Texas, May 06, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today provided an update on...
May 04, 2021 17:00 ET | Source: iBio, Inc.

iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement

BRYAN, Texas, May 04, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, announced today that...
March 09, 2021 16:30 ET | Source: iBio, Inc.

iBio to Participate in the 33rd Annual Roth Conference

BRYAN, Texas, March 09, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced that it...
February 16, 2021 16:05 ET | Source: iBio, Inc.

iBio Reports Fiscal Second Quarter 2021 Financial Results and Provides Corporate Update

BRYAN, Tx., Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced its financial...
February 16, 2021 08:00 ET | Source: iBio, Inc.

iBio Appoints Robert M. Lutz as Chief Financial & Business Officer

BRYAN, Texas, Feb. 16, 2021 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), a biotech innovator and biologics contract manufacturing organization, today announced the...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right